MMP2 and kidney disorder: Therefore, we focus on a CAD cohort without diabetes and proteinuria to appraise whether the estimated glomerular filtration rate (eGFR) decline rate in CAD is greater than that of subjects with normal coronary artery, and to assess whether circulating MMP-2, -3, and -9 levels at baseline could independently predict future progression of kidney disease and overall mortality.